Fort LP’s Cantel Medical Corporation CMD Stock Holding History

Fort LP’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-408	Closed	-$30K	–	518
2018 Q4	$30K	Buy	+408	New	+$33.7K	0.01%	373

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Fort LP's CMD Position: Q1 2019 in Review

Fort LP sold out of Cantel Medical Corporation (CMD) in Q1 2019, closing a stake of 408 shares — an estimated $30K sold.

Fort LP first reported a position in CMD in Q4 2018 and held it in 1 quarter. The position peaked at $30K in Q4 2018. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

Fort LP reported no remaining Cantel Medical Corporation position as of Q1 2019 after selling out during the quarter.
Fort LP sold 408 Cantel Medical Corporation shares in Q1 2019, an estimated $30K.
Fort LP first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 1 quarter.
Fort LP's Cantel Medical Corporation position peaked at $30K in Q4 2018.
254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on Fort LP's 13F filing for Q1 2019, filed 14 May 2019.